You are here

Pharmadrug Inc.

Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
PHRX
CSE Index: 
Currency: 

PharmaDrug is a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs. PharmaDrug owns 100% Sairiyo Therapeutics (“Sairiyo”), a biotech company that specializes in researching and reformulating established natural medicines with a goal of bringing them through clinical trials and the associated regulatory approval process in the US and Europe. Sairiyo is currently developing its patented reformulation of cepharanthine, a drug that has shown substantial third party validated potential for the treatment of infectious disease and rare cancers. Sairiyo is also conducting R&D in the psychedelics space for the treatment of non-neuropsychiatric conditions. The Company also owns 100% of Super Smart, a company building a vertically integrated retail business with the goal to elevate the use of functional mushrooms as natural based medicines.

You are here

Pharmadrug Inc. (PHRX)

SEDAR Information

Company Info

Address
77 King St. West, Suite 2905
Toronto, ON M5K 1H1
Canada
Phone
647-202-1824
Ext
6472021824
Fax
416-765-0029
Email
info@pharmadrug.co
Website
https://www.pharmadrug.ca
Listing date
Thursday, August 16, 2018
Transfer Agent
Capital Transfer Agency

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
355,626,346
Reserved for Issuance: 
75,502,328

Company Officers

Daniel Cohen, CFA, CEO
Keith Li, CPA, CFO

Bulletins

17/05/2023

2023-0527 - Reinstatement – Pharmadrug Inc. (PHRX)

le 17 mai/May 2023

Effective immediately, Pharmadrug Inc. will be reinstated for trading.

The Company has rectified the situation that gave rise to the suspension.

Advertisement

Publicité

Latest CSE News

Upcoming Events

Summit on Responsible Investment

Summit on Responsible Investment

Tuesday, June 27, 2023 -
9:00am to 7:00pm